Prognostic impact of bridge or neoadjuvant induction chemotherapy in patients with resected oral cavity cancer: A nationwide cohort study.

MLA

Hsu, Cheng‐Lung, et al. “Prognostic Impact of Bridge or Neoadjuvant Induction Chemotherapy in Patients with Resected Oral Cavity Cancer: A Nationwide Cohort Study.” Cancer Medicine, vol. 13, no. 15, Aug. 2024, pp. 1–20. EBSCOhost, https://doi.org/10.1002/cam4.70061.

APA

Hsu, C., Wen, Y., Wang, H., Hsieh, C., Liao, C., Lee, L., Ng, S., Lin, C., Chen, W., Lin, J., Tsai, Y., Lee, S., Chien, C., Hua, C., Wang, C. P., Chen, T., Terng, S., Tsai, C., Fan, K., & Yeh, C. (2024). Prognostic impact of bridge or neoadjuvant induction chemotherapy in patients with resected oral cavity cancer: A nationwide cohort study. Cancer Medicine, 13(15), 1–20. https://doi.org/10.1002/cam4.70061

Chicago

Hsu, Cheng‐Lung, Yu‐Wen Wen, Hung‐Ming Wang, Chia‐Hsun Hsieh, Chi‐Ting Liao, Li‐Yu Lee, Shu‐Hang Ng, et al. 2024. “Prognostic Impact of Bridge or Neoadjuvant Induction Chemotherapy in Patients with Resected Oral Cavity Cancer: A Nationwide Cohort Study.” Cancer Medicine 13 (15): 1–20. doi:10.1002/cam4.70061.